The global Wet Age Related Macular Degeneration (AMD) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Wet Age Related Macular Degeneration (AMD) market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Report Sample includes:
- Table of Contents
- List of Tables & Figures
- Charts
- Research Methodology
Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-wet-age-related-macular-degeneration-forecast-2023-2030-721
The China market for Global Wet Age Related Macular Degeneration (AMD) market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Wet Age Related Macular Degeneration (AMD) market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Increased disease burden due to rising geriatric population is one of the major factors driving the growth of the global age-related macular degeneration (AMD) market. This market is expected to surpass a valuation of USD 2,200 Mn by the end of 2023. AMD remains a major cause of central visual loss, effecting close to 10% of people older than 65 years and over 25% of people older than 75 years globally.
This report aims to provide a comprehensive presentation of the global market for Wet Age Related Macular Degeneration (AMD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wet Age Related Macular Degeneration (AMD). This report contains market size and forecasts of Wet Age Related Macular Degeneration (AMD) in global, including the following market information:
- Global Wet Age Related Macular Degeneration (AMD) Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
We surveyed the Wet Age Related Macular Degeneration (AMD) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment:
Global Wet Age Related Macular Degeneration (AMD) Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Wet Age Related Macular Degeneration (AMD) Market Segment Percentages, by Type, 2022 (%)
- Wet Age-Related Macular Degeneration (Wet AMD)
- Dry Age-Related Macular Degeneration (Dry AMD)
Global Wet Age Related Macular Degeneration (AMD) Market, by Age, 2018-2023, 2024-2030 ($ millions)
Global Wet Age Related Macular Degeneration (AMD) Market Segment Percentages, by Age, 2022 (%)
- Above 75 Years
- Above 60 Years
- Above 40 Years
Global Wet Age Related Macular Degeneration (AMD) Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Wet Age Related Macular Degeneration (AMD) Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Wet Age Related Macular Degeneration (AMD) revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Wet Age Related Macular Degeneration (AMD) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Novartis International (Switzerland)
- Bayer (Germany)
- Acucela (US)
- Neurotech Pharmaceuticals (US)
- Ophthotech (US)
- GlaxoSmithKline (US)
- Alimera Sciences (US)
- StemCell (Canada)
- F. Hoffmann-La Roche (Switzerland)
- Regeneron Pharmaceutical (US)
- Allergan (Ireland)
- Adverum Biotechnologies (US)
- Gilead Sciences (US)
Chapter 1: Introduces the definition of Wet Age Related Macular Degeneration (AMD), market overview.
Chapter 2: Global Wet Age Related Macular Degeneration (AMD) market size in revenue.
Chapter 3: Detailed analysis of Wet Age Related Macular Degeneration (AMD) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by age, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Wet Age Related Macular Degeneration (AMD) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Get the Complete Report & TOC at https://www.24marketreports.com/life-sciences/global-wet-age-related-macular-degeneration-forecast-2023-2030-721CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports